Unnamed: 0,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0007159,GO:0007159,leukocyte cell-cell adhesion,34/128,381/18800,1.3254265059136598e-28,4.73309805261767e-25,2.51133443225746e-25,B2M/CD274/CD28/CD70/CD74/CD80/CD83/EPO/EZR/GCNT1/HAVCR2/HLA-E/ICAM1/IFNG/IL10/IL12B/IL12RB1/IL15/IL18/IL2RA/IL6/JAM2/KLRK1/LAG3/LGALS1/LGALS9/LILRB4/SDC4/TGFBR2/THY1/TNF/TNFSF13B/VCAM1/VSIG4,34
GO:0002696,GO:0002696,positive regulation of leukocyte activation,34/128,421/18800,3.75520675018691e-27,6.70492165245873e-24,3.55756428965076e-24,AXL/B2M/BCL2/CCL3/CD274/CD28/CD70/CD74/CD80/CD83/EPO/HAVCR2/HLA-E/IFNG/IL10/IL12B/IL12RB1/IL15/IL15RA/IL18/IL2RA/IL6/KLRK1/LGALS1/LGALS9/LILRB4/NECTIN2/TGFBR2/THY1/TNF/TNFRSF4/TNFSF13/TNFSF13B/VCAM1,34
GO:0070663,GO:0070663,regulation of leukocyte proliferation,28/128,254/18800,4.16836034014084e-26,3.72130369366074e-23,1.97448647690882e-23,BCL2/CD274/CD28/CD70/CD74/CD80/CSF1/EPO/HAVCR2/HLA-E/IL10/IL12B/IL12RB1/IL15/IL18/IL2RA/IL5RA/IL6/LGALS9/LILRB4/SDC4/TGFBR2/TNFRSF13B/TNFRSF1B/TNFRSF4/TNFSF13B/VCAM1/VSIG4,28
GO:0022409,GO:0022409,positive regulation of cell-cell adhesion,29/128,291/18800,9.32166310633203e-26,5.54794315878528e-23,2.94368308621011e-23,B2M/CD274/CD28/CD70/CD74/CD80/CD83/CXCL13/EPO/FSTL3/HAVCR2/HLA-E/IFNG/IL10/IL12B/IL12RB1/IL15/IL18/IL2RA/IL6/KLRK1/LGALS1/LGALS9/LILRB4/TGFBR2/THY1/TNF/TNFSF13B/VCAM1,29
GO:0050863,GO:0050863,regulation of T cell activation,30/128,342/18800,5.41857571061985e-25,2.41871673282794e-22,1.28334687883102e-22,B2M/CD274/CD28/CD70/CD74/CD80/CD83/EPO/HAVCR2/HLA-E/IFNG/IL10/IL12B/IL12RB1/IL15/IL18/IL2RA/IL6/KLRK1/LAG3/LGALS1/LGALS9/LILRB4/SDC4/TGFBR2/THY1/TNFRSF1B/TNFSF13B/VCAM1/VSIG4,30
GO:0050670,GO:0050670,regulation of lymphocyte proliferation,26/128,230/18800,1.5045928055002e-24,5.372900908441209e-22,2.85080742094774e-22,BCL2/CD274/CD28/CD70/CD74/CD80/EPO/HAVCR2/HLA-E/IL10/IL12B/IL12RB1/IL15/IL18/IL2RA/IL6/LGALS9/LILRB4/SDC4/TGFBR2/TNFRSF13B/TNFRSF1B/TNFRSF4/TNFSF13B/VCAM1/VSIG4,26
GO:0050870,GO:0050870,positive regulation of T cell activation,25/128,223/18800,1.57290237731133e-23,4.01202456384197e-21,2.12874005951909e-21,B2M/CD274/CD28/CD70/CD74/CD80/CD83/EPO/HAVCR2/HLA-E/IFNG/IL12B/IL12RB1/IL15/IL18/IL2RA/IL6/KLRK1/LGALS1/LGALS9/LILRB4/TGFBR2/THY1/TNFSF13B/VCAM1,25
GO:0070661,GO:0070661,leukocyte proliferation,28/128,330/18800,6.16397920240716e-23,1.46743798211973e-20,7.7860789925143e-21,BCL2/CD274/CD28/CD70/CD74/CD80/CSF1/EPO/HAVCR2/HLA-E/IL10/IL12B/IL12RB1/IL15/IL18/IL2RA/IL5RA/IL6/LGALS9/LILRB4/SDC4/TGFBR2/TNFRSF13B/TNFRSF1B/TNFRSF4/TNFSF13B/VCAM1/VSIG4,28
GO:0042098,GO:0042098,T cell proliferation,23/128,204/18800,9.50245455731066e-22,1.69666326120782e-19,9.00232537008379e-20,CD274/CD28/CD70/CD80/EPO/HAVCR2/HLA-E/IL10/IL12B/IL12RB1/IL15/IL18/IL2RA/IL6/LGALS9/LILRB4/SDC4/TGFBR2/TNFRSF1B/TNFRSF4/TNFSF13B/VCAM1/VSIG4,23
GO:0002237,GO:0002237,response to molecule of bacterial origin,27/128,354/18800,6.57533816763851e-21,1.02089272159292e-18,5.41675455457634e-19,ADAM9/AXL/B2M/CCL3/CD14/CD274/CD80/CSF3/CXCL10/CXCL13/CXCL9/EPO/FGFR2/HAVCR2/IL10/IL12B/IL18/IL18BP/IL6/KLRK1/LGALS9/NOS3/THBD/THPO/TNF/TNFRSF1B/VCAM1,27
GO:0002697,GO:0002697,regulation of immune effector process,26/128,353/18800,9.09925353662238e-20,1.29973737517114e-17,6.89627636459802e-18,B2M/CD28/CD59/CD74/CD80/HAVCR2/HLA-E/ICAM1/IFNG/IL10/IL12B/IL12RB1/IL18/IL6/KLRK1/LAG3/LGALS9/LILRB4/NCR1/NECTIN2/SLAMF8/TNF/TNFRSF1B/TNFRSF4/TNFSF13/VSIG4,26
GO:1903131,GO:1903131,mononuclear cell differentiation,28/128,433/18800,9.62079882161646e-20,1.3213797150766301e-17,7.01110845299985e-18,AXL/B2M/BCL2/CD28/CD74/CD79B/CD80/CD83/CSF1/DLL1/IFNG/IL10/IL12B/IL12RB1/IL15/IL15RA/IL18/IL2RA/IL6/LAG3/LGALS1/LGALS9/LILRB4/LTBR/SLAMF8/TGFBR2/TNFSF13B/VCAM1,28
GO:0019221,GO:0019221,cytokine-mediated signaling pathway,29/128,486/18800,1.7604066734187501e-19,2.3283008262142e-17,1.2353731041535101e-17,AXL/CCL3/CD70/CD74/CSF1/CSF3/CXCL10/CXCL13/CXCL9/EDA2R/EPO/IFNG/IL12B/IL12RB1/IL15/IL15RA/IL18/IL2RA/IL5RA/IL6/LILRB4/THPO/TNF/TNFRSF19/TNFRSF1A/TNFRSF1B/TNFRSF4/TNFSF13B/YAP1,29
GO:1903706,GO:1903706,regulation of hemopoiesis,26/128,371/18800,3.15741561254566e-19,4.02683255442876e-17,2.13659703104593e-17,AXL/B2M/CCL3/CD28/CD74/CD80/CD83/CSF1/CSF3/DLL1/FSTL3/IFNG/IL10/IL12B/IL12RB1/IL15/IL15RA/IL18/IL2RA/LAG3/LGALS9/LILRB4/SLAMF8/TGFBR2/THPO/TNF,26
GO:0002460,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,23/128,370/18800,6.16253554560319e-16,5.50160360833725e-14,2.91909578475941e-14,B2M/BTN3A2/CD274/CD28/CD70/CD74/CD80/CXCL13/HAVCR2/HLA-E/ICAM1/IL10/IL12B/IL12RB1/IL18/IL18BP/IL6/LILRB4/NECTIN2/TNF/TNFRSF1B/TNFSF13/TNFSF13B,23
GO:0071216,GO:0071216,cellular response to biotic stimulus,20/128,256/18800,7.37429246517998e-16,6.42282887637993e-14,3.40788868737457e-14,ADAM9/AXL/CCL3/CD14/CD274/CD80/CSF3/CXCL10/CXCL13/CXCL9/HAVCR2/IL10/IL12B/IL18/IL6/KLRK1/NOS3/THPO/TNF/TNFRSF1B,20
GO:0002274,GO:0002274,myeloid leukocyte activation,19/128,232/18800,1.7313163366879201e-15,1.47203110436013e-13,7.81044963919361e-14,ADAM9/CCL3/CD200/CD74/CSF1/HAVCR2/IFNG/IL10/IL15/IL18/IL6/LGALS9/LILRB4/LTBR/NECTIN2/PTGDS/TGFBR2/TNF/VSIG4,19
GO:0002822,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,17/128,173/18800,2.7869545545376703e-15,2.26186698051227e-13,1.20012397085354e-13,B2M/CD274/CD28/CD80/HAVCR2/HLA-E/IL10/IL12B/IL12RB1/IL18/IL6/LILRB4/NECTIN2/TNF/TNFRSF1B/TNFSF13/TNFSF13B,17
GO:0002449,GO:0002449,lymphocyte mediated immunity,22/128,365/18800,5.344404619246051e-15,4.24108197673948e-13,2.25027562915623e-13,B2M/BTN3A2/CD28/CD70/CD74/HAVCR2/HLA-E/ICAM1/IL10/IL12B/IL12RB1/IL18/IL6/KLRK1/LAG3/LGALS9/LILRB4/NCR1/NECTIN2/TNF/TNFRSF1B/TNFSF13,22
GO:0001819,GO:0001819,positive regulation of cytokine production,24/128,475/18800,1.37082837092181e-14,1.0198391901170399e-12,5.41116462205979e-13,B2M/BTN3A2/CCL3/CD14/CD200/CD274/CD28/CD74/CD80/CD83/HAVCR2/HLA-E/IFNG/IL10/IL12B/IL12RB1/IL15/IL18/IL6/KLRK1/LGALS9/ORM1/TNF/TNFRSF8,24
GO:0031341,GO:0031341,regulation of cell killing,13/128,100/18800,1.56356096692043e-13,1.10949297500748e-11,5.88685862728549e-12,B2M/CD59/HAVCR2/HLA-E/ICAM1/IFNG/IL12B/IL12RB1/KLRK1/LAG3/LGALS9/NCR1/NECTIN2,13
GO:0050900,GO:0050900,leukocyte migration,21/128,384/18800,1.58454611384434e-13,1.10949297500748e-11,5.88685862728549e-12,B4GALT1/CCL3/CCN3/CD200/CD74/CSF1/CXCL10/CXCL13/CXCL9/GCNT1/ICAM1/IL10/IL6/JAM2/KLRK1/LGALS9/PGF/SLAMF8/THY1/TNF/VCAM1,21
GO:0046631,GO:0046631,alpha-beta T cell activation,15/128,158/18800,2.19413364450448e-13,1.50677908548567e-11,7.994818947587159e-12,BCL2/CD274/CD28/CD80/CD83/HLA-E/IFNG/IL12B/IL12RB1/IL15/IL18/IL6/LGALS9/LILRB4/TGFBR2,15
GO:0032103,GO:0032103,positive regulation of response to external stimulus,22/128,442/18800,2.64596647439346e-13,1.7827823169922797e-11,9.459264456620129e-12,CCL3/CD28/CD74/CSF1/CXCL10/CXCL13/HAVCR2/HLA-E/IFNG/IL12B/IL15/IL18/IL6/KLRK1/LAG3/LGALS1/LGALS9/NECTIN2/PGF/THBD/TNF/TNFRSF1A,22
GO:0032609,GO:0032609,interferon-gamma production,13/128,117/18800,1.23525782731013e-12,7.87697446665082e-11,4.17944377661321e-11,AXL/BTN3A2/CD14/CD274/HAVCR2/IL10/IL12B/IL12RB1/IL18/KLRK1/LGALS9/LILRB4/TNF,13
GO:0050866,GO:0050866,negative regulation of cell activation,16/128,216/18800,1.58512770337179e-12,9.930686015334489e-11,5.26912255968462e-11,AXL/CD200/CD274/CD74/CD80/HAVCR2/IL10/IL2RA/LAG3/LGALS9/LILRB4/NOS3/SDC4/THBD/TNFRSF13B/VSIG4,16
GO:0002685,GO:0002685,regulation of leukocyte migration,16/128,218/18800,1.82606434646042e-12,1.12428892779485e-10,5.96536447119556e-11,CCL3/CCN3/CD200/CD74/CSF1/CXCL10/CXCL13/ICAM1/IL6/JAM2/KLRK1/LGALS9/PGF/SLAMF8/THY1/TNF,16
GO:0002285,GO:0002285,lymphocyte activation involved in immune response,15/128,201/18800,7.38944967495104e-12,4.18852774432542e-10,2.22239087968452e-10,CD28/CD74/CD80/DLL1/HAVCR2/ICAM1/IFNG/IL10/IL12B/IL12RB1/IL18/IL6/LGALS1/LGALS9/TNFSF13,15
GO:0018108,GO:0018108,peptidyl-tyrosine phosphorylation,19/128,373/18800,8.73091188504683e-12,4.87157599085973e-10,2.58480943965202e-10,AXL/CD74/CD80/CSF3/EFNA1/EPHA2/EPHB4/EPO/FGFR2/GFRA1/IFNG/IL12B/IL15/IL18/IL6/LILRB4/THY1/TNF/TNFRSF1A,19
GO:0001910,GO:0001910,regulation of leukocyte mediated cytotoxicity,11/128,85/18800,1.3121427301594299e-11,6.79081404260772e-10,3.60313793178791e-10,B2M/HAVCR2/HLA-E/ICAM1/IL12B/IL12RB1/KLRK1/LAG3/LGALS9/NCR1/NECTIN2,11
GO:0002456,GO:0002456,T cell mediated immunity,12/128,112/18800,1.45852089927403e-11,7.44054018758225e-10,3.94787611833573e-10,B2M/BTN3A2/CD70/HLA-E/ICAM1/IL12B/IL12RB1/IL18/IL6/LILRB4/NECTIN2/TNFRSF1B,12
GO:0002507,GO:0002507,tolerance induction,8/128,31/18800,2.5604289005349097e-11,1.25250569915208e-09,6.64566982114324e-10,CD274/HAVCR2/HLA-E/IL2RA/LGALS9/LILRB4/PDCD1/TGFBR2,8
GO:0001906,GO:0001906,cell killing,14/128,185/18800,3.1836991385910495e-11,1.53634994917684e-09,8.151718989280061e-10,B2M/CD59/HAVCR2/HLA-E/ICAM1/IFNG/IL12B/IL12RB1/IL18/KLRK1/LAG3/LGALS9/NCR1/NECTIN2,14
GO:0001909,GO:0001909,leukocyte mediated cytotoxicity,12/128,131/18800,9.3967323950778e-11,4.14268288676825e-09,2.1980660573281403e-09,B2M/HAVCR2/HLA-E/ICAM1/IL12B/IL12RB1/IL18/KLRK1/LAG3/LGALS9/NCR1/NECTIN2,12
GO:0032102,GO:0032102,negative regulation of response to external stimulus,19/128,429/18800,9.67858157226427e-11,4.2149042432385e-09,2.23638598588905e-09,CCN3/CD200/CXCL13/HAVCR2/HLA-E/IL10/IL12B/IL2RA/KLRK1/LGALS9/NOS3/SEMA3F/SIGLEC10/SLAMF8/THBD/TNF/TNFRSF1A/TNFRSF1B/VSIG4,19
GO:0050727,GO:0050727,regulation of inflammatory response,18/128,394/18800,1.90966828779909e-10,8.022853477330071e-09,4.25684571893296e-09,CCL3/CCN3/CD200/CD28/HLA-E/IFNG/IL10/IL12B/IL15/IL18/IL2RA/IL6/LGALS1/SIGLEC10/SLAMF8/TNF/TNFRSF1A/TNFRSF1B,18
GO:0042269,GO:0042269,regulation of natural killer cell mediated cytotoxicity,8/128,46/18800,7.77642209242981e-10,2.72251012667322e-08,1.44453661159687e-08,HAVCR2/HLA-E/IL12B/KLRK1/LAG3/LGALS9/NCR1/NECTIN2,8
GO:0042267,GO:0042267,natural killer cell mediated cytotoxicity,9/128,72/18800,1.4028731952227802e-09,4.47291087512548e-08,2.37328172124154e-08,HAVCR2/HLA-E/IL12B/IL18/KLRK1/LAG3/LGALS9/NCR1/NECTIN2,9
GO:0002700,GO:0002700,regulation of production of molecular mediator of immune response,12/128,167/18800,1.57972885492348e-09,4.94843135169452e-08,2.62558812452656e-08,B2M/CD28/CD74/HLA-E/IL10/IL18/IL6/LILRB4/TNF/TNFRSF1B/TNFRSF4/TNFSF13,12
GO:0034612,GO:0034612,response to tumor necrosis factor,14/128,249/18800,1.6146570903322102e-09,5.01386127789245e-08,2.66030458819037e-08,ADAM9/CCL3/CD14/CD70/EDA2R/GBP1/IL18BP/TNF/TNFRSF19/TNFRSF1A/TNFRSF1B/TNFRSF4/TNFSF13B/VCAM1,14
GO:0048659,GO:0048659,smooth muscle cell proliferation,12/128,173/18800,2.3651033303285303e-09,6.97998677074644e-08,3.70351108707382e-08,CCN3/FGFR2/IFNG/IL10/IL12B/IL15/IL18/IL6/NOS3/OGN/TGFBR2/TNF,12
GO:0060326,GO:0060326,cell chemotaxis,15/128,315/18800,3.97248115355748e-09,1.1348584159483e-07,6.02144511697134e-08,CCL3/CCN3/CD74/CSF1/CXCL10/CXCL13/CXCL9/EPHA2/IL10/IL6/KLRK1/LGALS9/PGF/SLAMF8/VCAM1,15
GO:0006959,GO:0006959,humoral immune response,15/128,317/18800,4.327976626594431e-09,1.20743785418505e-07,6.40654434857727e-08,BCL2/CD28/CD59/CD83/CXCL10/CXCL13/CXCL9/HLA-E/IFNG/IL6/PDCD1/REG3A/TNF/VSIG4/WFDC2,15
GO:0019058,GO:0019058,viral life cycle,15/128,317/18800,4.327976626594431e-09,1.20743785418505e-07,6.40654434857727e-08,AXL/BCL2/CD28/CD74/CD80/EPHA2/ICAM1/LAMP3/LGALS1/LGALS9/NECTIN2/SCARB2/SIGLEC1/TNF/TNFRSF4,15
GO:0046718,GO:0046718,viral entry into host cell,11/128,146/18800,4.7443212836777405e-09,1.30322856184717e-07,6.91480025151411e-08,AXL/CD74/CD80/EPHA2/ICAM1/LGALS1/LGALS9/NECTIN2/SCARB2/SIGLEC1/TNFRSF4,11
GO:0002709,GO:0002709,regulation of T cell mediated immunity,9/128,88/18800,8.594886123482942e-09,2.22408248890997e-07,1.18007589796104e-07,B2M/HLA-E/IL12B/IL12RB1/IL18/IL6/LILRB4/NECTIN2/TNFRSF1B,9
GO:0042113,GO:0042113,B cell activation,15/128,336/18800,9.48056856661479e-09,2.43561944973967e-07,1.29231529117051e-07,BCL2/CD28/CD70/CD74/CD79B/DLL1/IL10/IL6/LGALS1/SLAMF8/TNFRSF13B/TNFRSF4/TNFSF13/TNFSF13B/VCAM1,15
GO:0048660,GO:0048660,regulation of smooth muscle cell proliferation,11/128,170/18800,2.33179797553707e-08,5.58849031586771e-07,2.96519700174266e-07,FGFR2/IFNG/IL10/IL12B/IL15/IL18/IL6/NOS3/OGN/TGFBR2/TNF,11
GO:0002367,GO:0002367,cytokine production involved in immune response,9/128,100/18800,2.67204284476058e-08,6.31911589313909e-07,3.35285961698783e-07,B2M/CD74/HLA-E/IL10/IL18/IL6/LILRB4/TNF/TNFRSF1B,9
GO:0043410,GO:0043410,positive regulation of MAPK cascade,17/128,491/18800,3.95642526933584e-08,8.9989774756677e-07,4.77476733811902e-07,ADAM9/CCL3/CD74/EDA2R/EDAR/EFNA1/EPO/FGFR2/HAVCR2/ICAM1/IGFBP4/IL6/LGALS9/LTBR/THPO/TNF/TNFRSF19,17
GO:0050920,GO:0050920,regulation of chemotaxis,12/128,225/18800,4.50789953595394e-08,1.00610682768072e-06,5.33830208205072e-07,CCL3/CCN3/CD74/CSF1/CXCL10/CXCL13/IL6/KLRK1/LGALS9/PGF/SEMA3F/SLAMF8,12
GO:0071887,GO:0071887,leukocyte apoptotic process,9/128,109/18800,5.68883831870561e-08,1.25400257012949e-06,6.65361206866153e-07,AXL/CD274/CD74/EFNA1/IL10/IL2RA/IL6/LGALS9/PDCD1,9
GO:0031099,GO:0031099,regeneration,11/128,188/18800,6.57204666144743e-08,1.43980236981772e-06,7.63944720090757e-07,AXL/BCL2/CCN3/IL10/IL6/NEFL/PGF/TGFBR2/THY1/TNF/YAP1,11
GO:0048872,GO:0048872,homeostasis of number of cells,13/128,282/18800,6.71789206109322e-08,1.46278003354658e-06,7.76136438380475e-07,AXL/B2M/BCL2/CCN3/CD74/CSF1/EPO/IL2RA/IL6/LGALS9/NOS3/TNFRSF13B/TNFSF13B,13
GO:0050777,GO:0050777,negative regulation of immune response,10/128,179/18800,4.09640343577744e-07,7.65877312521531e-06,4.06366832978749e-06,CD59/HAVCR2/HLA-E/IL10/IL12B/LGALS9/LILRB4/PDCD1/SLAMF8/VSIG4,10
GO:1903900,GO:1903900,regulation of viral life cycle,9/128,139/18800,4.60715353381154e-07,8.52442760064301e-06,4.52297592629439e-06,AXL/BCL2/CD28/CD74/LAMP3/LGALS1/LGALS9/NECTIN2/TNF,9
GO:0051043,GO:0051043,regulation of membrane protein ectodomain proteolysis,5/128,24/18800,5.18214267972806e-07,9.4415466884229e-06,5.009590130779e-06,ADAM9/IFNG/IL10/TNF/TNFRSF1B,5
GO:0097696,GO:0097696,receptor signaling pathway via STAT,10/128,184/18800,5.2808009632933e-07,9.57245697457888e-06,5.07904981775471e-06,EPO/IFNG/IL10/IL12B/IL15/IL18/IL6/THPO/TNF/TNFRSF1A,10
GO:0150076,GO:0150076,neuroinflammatory response,7/128,73/18800,6.45168779883542e-07,1.13492498175573e-05,6.02179830848004e-06,CCL3/CD200/IFNG/IL18/IL6/TNF/TNFRSF1B,7
GO:0002437,GO:0002437,inflammatory response to antigenic stimulus,7/128,75/18800,7.77124308024718e-07,1.34063328693539e-05,7.11326597734295e-06,CD28/HLA-E/IL10/IL12B/IL2RA/IL5RA/TNF,7
GO:0002831,GO:0002831,regulation of response to biotic stimulus,13/128,351/18800,8.23343674209374e-07,1.40677524430702e-05,7.46420858009002e-06,CD274/HAVCR2/HLA-E/IL12B/IL12RB1/IL15/KLRK1/LAG3/LGALS9/NCR1/NECTIN2/SLAMF8/VSIG4,13
GO:0033674,GO:0033674,positive regulation of kinase activity,15/128,476/18800,8.70200910939758e-07,1.46579596838013e-05,7.77736663203359e-06,ADAM9/AXL/CD74/CSF1/EFNA1/EPHA2/EPHB4/EPO/FGFR2/IFNG/IL12B/IL18/SDC4/TGFBR2/TNF,15
GO:0002526,GO:0002526,acute inflammatory response,8/128,113/18800,1.04222528677621e-06,1.73106348794318e-05,9.18484952850511e-06,B4GALT1/EPO/HLA-E/IL6/ORM1/REG3A/TNF/VCAM1,8
GO:0002064,GO:0002064,epithelial cell development,10/128,203/18800,1.29583491090561e-06,2.09385812979364e-05,1.1109801570041e-05,B4GALT1/COL18A1/DLL1/EPHA2/EZR/ICAM1/STC1/TNF/TNFRSF1A/YAP1,10
GO:0002440,GO:0002440,production of molecular mediator of immune response,12/128,312/18800,1.50544851470993e-06,2.36826283966043e-05,1.25657654833196e-05,B2M/CD28/CD74/HLA-E/IL10/IL18/IL6/LILRB4/TNF/TNFRSF1B/TNFRSF4/TNFSF13,12
GO:1901214,GO:1901214,regulation of neuron death,12/128,313/18800,1.5565164744464e-06,2.43785979396846e-05,1.29350399538482e-05,AXL/BCL2/CCL3/CD200/CSF1/CSF3/EPO/IFNG/IL10/NEFL/TNF/TNFRSF1B,12
GO:2000106,GO:2000106,regulation of leukocyte apoptotic process,7/128,85/18800,1.8267359545988e-06,2.83620612777057e-05,1.5048625712942e-05,AXL/CD274/CD74/EFNA1/IL10/LGALS9/PDCD1,7
GO:0022612,GO:0022612,gland morphogenesis,8/128,123/18800,1.98183900055965e-06,3.05049442715453e-05,1.61856179719028e-05,BCL2/CSF1/EDAR/EPHA2/FGFR2/IL6/TGFBR2/TNF,8
GO:0097191,GO:0097191,extrinsic apoptotic signaling pathway,10/128,221/18800,2.78532810908819e-06,4.14433611564747e-05,2.19894324401699e-05,BCL2/CD70/ICAM1/IFNG/LTBR/NOS3/TNF/TNFRSF1A/TNFRSF1B/YAP1,10
GO:0022614,GO:0022614,membrane to membrane docking,3/128,5/18800,3.05237370306712e-06,4.50414317919532e-05,2.38985326903906e-05,EZR/ICAM1/VCAM1,3
GO:0003158,GO:0003158,endothelium development,8/128,133/18800,3.56238450402859e-06,5.17125002596996e-05,2.74381348192189e-05,COL18A1/CXCL10/DLL1/EZR/ICAM1/STC1/TNF/TNFRSF1A,8
GO:0034113,GO:0034113,heterotypic cell-cell adhesion,6/128,61/18800,3.61824683109733e-06,5.23107669386582e-05,2.77555691283835e-05,CD200/DSC2/IL10/THY1/TNF/VCAM1,6
GO:0045765,GO:0045765,regulation of angiogenesis,12/128,345/18800,4.25071296989462e-06,6.02353016487845e-05,3.19602478939445e-05,CXCL10/CXCL13/DLL1/EFNA1/EPHA2/HSPG2/IL10/IL6/NOS3/PGF/TGFBR2/TNF,12
GO:0002544,GO:0002544,chronic inflammatory response,4/128,17/18800,4.55548259902589e-06,6.28093759116659e-05,3.33260259225629e-05,CXCL13/IL10/TNF/VCAM1,4
GO:0051384,GO:0051384,response to glucocorticoid,8/128,139/18800,4.94727155355955e-06,6.74301783120654e-05,3.57777774062161e-05,ADAM9/BCL2/EPO/IL10/IL6/NEFL/STC1/TNF,8
GO:0034341,GO:0034341,response to interferon-gamma,8/128,140/18800,5.21743551082417e-06,7.00430910118537e-05,3.7164162720552e-05,CCL3/CD74/GBP1/IFNG/IL12B/IL12RB1/LGALS9/TNF,8
GO:0031100,GO:0031100,animal organ regeneration,6/128,65/18800,5.26415671034515e-06,7.01429239277707e-05,3.72171330660694e-05,AXL/IL10/IL6/PGF/TGFBR2/TNF,6
GO:0070997,GO:0070997,neuron death,12/128,353/18800,5.3694662917739e-06,7.10161634367578e-05,3.76804652054309e-05,AXL/BCL2/CCL3/CD200/CSF1/CSF3/EPO/IFNG/IL10/NEFL/TNF/TNFRSF1B,12
GO:0002478,GO:0002478,antigen processing and presentation of exogenous peptide antigen,5/128,38/18800,5.66996798160704e-06,7.36271114993408e-05,3.90658081029384e-05,B2M/CD74/CTSV/HLA-E/IFI30,5
GO:0042742,GO:0042742,defense response to bacterium,12/128,364/18800,7.32762968453512e-06,9.24481317053598e-05,4.90520529616199e-05,CXCL13/EPHA2/HAVCR2/HLA-E/IL10/IL12B/IL6/KLRK1/SLAMF8/TNF/TNFRSF1A/WFDC2,12
GO:0031645,GO:0031645,negative regulation of nervous system process,4/128,19/18800,7.34101329690192e-06,9.24481317053598e-05,4.90520529616199e-05,CCN3/IL10/JAM2/TNF,4
GO:0060284,GO:0060284,regulation of cell development,14/128,500/18800,8.03601825261362e-06,0.0001003378362939,5.32382512134873e-05,B2M/BCL2/DLL1/GBP1/IFNG/IL6/NEFL/SEMA3F/SLAMF8/THY1/TNF/TNFRSF1A/TNFRSF1B/YAP1,14
GO:0002837,GO:0002837,regulation of immune response to tumor cell,4/128,20/18800,9.1279668160508e-06,0.0001127888217997,5.98446194459714e-05,CD274/HAVCR2/IL12B/NECTIN2,4
GO:0050673,GO:0050673,epithelial cell proliferation,13/128,443/18800,1.05009694749736e-05,0.0001271151254072,6.74460126849331e-05,B2M/B4GALT1/CCN3/EPHA2/FGFR2/IGFBP4/IL10/IL12B/IL6/PGF/REG3A/TNF/YAP1,13
GO:0006509,GO:0006509,membrane protein ectodomain proteolysis,5/128,44/18800,1.18732232110492e-05,0.000142279463378,7.54920585654838e-05,ADAM9/IFNG/IL10/TNF/TNFRSF1B,5
GO:0044706,GO:0044706,multi-multicellular organism process,9/128,213/18800,1.54499393019294e-05,0.0001774010715343,9.41272321660956e-05,B4GALT1/BCL2/EPO/HAVCR2/LGALS9/PGF/STC1/TGFBR2/THBD,9
GO:0045445,GO:0045445,myoblast differentiation,6/128,81/18800,1.89254316631552e-05,0.0002111104863773,0.0001120131101355,CXCL10/CXCL9/DLL1/IL18/LGALS1/TNF,6
GO:0051048,GO:0051048,negative regulation of secretion,8/128,167/18800,1.89768877421297e-05,0.0002111104863773,0.0001120131101355,CCN3/CD200/CD74/IL12B/LGALS9/TNF/TNFRSF1A/TNFRSF1B,8
GO:0048639,GO:0048639,positive regulation of developmental growth,8/128,169/18800,2.06801973101145e-05,0.0002258378733774,0.0001198273142063,AGRN/BCL2/CSF1/DLL1/EZR/FGFR2/TGFBR2/YAP1,8
GO:0045662,GO:0045662,negative regulation of myoblast differentiation,4/128,25/18800,2.32122489940615e-05,0.0002496715095114,0.000132473202883,CXCL10/DLL1/IL18/TNF,4
GO:0001667,GO:0001667,ameboidal-type cell migration,13/128,480/18800,2.4430831479003e-05,0.0002619894871216,0.000139008998458,ADAM9/CCN3/CXCL13/EFNA1/EPHA2/EPHB4/IFNG/NOS3/SDC4/SEMA3F/STC1/TGFBR2/TNF,13
GO:0048771,GO:0048771,tissue remodeling,8/128,174/18800,2.55085365480967e-05,0.0002702996558256,0.0001434182907592,AXL/CST3/EPHA2/IL12B/IL15/IL18/IL6/NOS3,8
GO:0033627,GO:0033627,cell adhesion mediated by integrin,6/128,86/18800,2.66669453117306e-05,0.0002809075566613,0.0001490467367213,ADAM9/CCN3/CXCL13/EFNA1/EPHA2/ICAM1,6
GO:0008544,GO:0008544,epidermis development,11/128,355/18800,3.16551216999372e-05,0.0003307933242302,0.0001755156254666,ADAM9/BCL2/DLL1/EDA2R/EDAR/EPHA2/FGFR2/REG3A/TNF/TNFRSF19/YAP1,11
GO:0002418,GO:0002418,immune response to tumor cell,4/128,27/18800,3.18658368902823e-05,0.0003307933242302,0.0001755156254666,CD274/HAVCR2/IL12B/NECTIN2,4
GO:0090132,GO:0090132,epithelium migration,11/128,361/18800,3.68745181069152e-05,0.0003751535731048,0.000199052729322,ADAM9/CCN3/CXCL13/EFNA1/EPHA2/EPHB4/IFNG/NOS3/STC1/TGFBR2/TNF,11
GO:0042060,GO:0042060,wound healing,12/128,429/18800,3.7282851272195e-05,0.0003771588155609,0.0002001166908899,AXL/B4GALT1/CD59/FGFR2/IL6/NOS3/REG3A/SDC4/TGFBR2/THBD/TNF/YAP1,12
GO:0007565,GO:0007565,female pregnancy,8/128,185/18800,3.95266398485124e-05,0.0003964877272444,0.0002103724178809,BCL2/EPO/HAVCR2/LGALS9/PGF/STC1/TGFBR2/THBD,8
GO:0061138,GO:0061138,morphogenesis of a branching epithelium,8/128,185/18800,3.95266398485124e-05,0.0003964877272444,0.0002103724178809,BCL2/CSF1/EPHA2/FGFR2/IL10/TGFBR2/TNF/YAP1,8
GO:0098773,GO:0098773,skin epidermis development,6/128,93/18800,4.15883991296664e-05,0.0004160004854118,0.0002207256919752,BCL2/DLL1/EDAR/FGFR2/TNF/TNFRSF19,6
GO:0060557,GO:0060557,positive regulation of vitamin D biosynthetic process,2/128,2/18800,4.59961088921661e-05,0.0004439246077133,0.0002355419516526,IFNG/TNF,2
GO:0051960,GO:0051960,regulation of nervous system development,12/128,440/18800,4.76163423161843e-05,0.0004558658402442,0.000241877850061,AGRN/B2M/DLL1/IFNG/IL6/JAM2/NEFL/SEMA3F/THY1/TNF/TNFRSF1B/YAP1,12
GO:0006898,GO:0006898,receptor-mediated endocytosis,9/128,246/18800,4.79081687004554e-05,0.0004574333433939,0.0002427095515362,B2M/CD14/DLL1/EZR/HSPG2/LILRB4/SCARB2/SIGLEC1/TGFBR2,9
GO:0075294,GO:0075294,positive regulation by symbiont of entry into host,3/128,11/18800,4.88776221637363e-05,0.0004639401462468,0.0002461619959746,CD74/LGALS1/LGALS9,3
GO:0001763,GO:0001763,morphogenesis of a branching structure,8/128,199/18800,6.6172609538519e-05,0.0006106004874988,0.0003239785044725,BCL2/CSF1/EPHA2/FGFR2/IL10/TGFBR2/TNF/YAP1,8
GO:0007584,GO:0007584,response to nutrient,7/128,150/18800,7.55436971372947e-05,0.0006864288612653,0.0003642122802923,CXCL10/EPO/FOLR2/IL15/STC1/TGFBR2/VCAM1,7
GO:0009615,GO:0009615,response to virus,11/128,392/18800,7.73607246936417e-05,0.0007011551976674,0.0003720259269264,BCL2/CXCL10/CXCL9/GBP1/IFNG/IL12B/IL12RB1/IL15/IL6/LGALS9/TNF,11
GO:0003170,GO:0003170,heart valve development,5/128,65/18800,8.05602423914707e-05,0.0007228156421606,0.0003835187418795,EFNA1/NOS3/TGFBR2/TNFRSF1A/TNFRSF1B,5
GO:1903054,GO:1903054,negative regulation of extracellular matrix organization,3/128,13/18800,8.38803220206335e-05,0.0007341584067051,0.000389537099167,CST3/TNFRSF1A/TNFRSF1B,3
GO:0040013,GO:0040013,negative regulation of locomotion,11/128,396/18800,8.46641986464476e-05,0.0007392074654436,0.0003922160791754,BCL2/CCN3/CD200/CD74/CXCL13/KLRK1/SEMA3F/SLAMF8/STC1/THY1/TNF,11
GO:0042092,GO:0042092,type 2 immune response,4/128,37/18800,0.0001137682780409,0.0009627168741328,0.000510807933334,CD74/IL10/IL18/IL6,4
GO:0007568,GO:0007568,aging,7/128,163/18800,0.0001271178868911,0.0010606027431972,0.000562745195288,EPO/GFRA1/IL10/IL15/TGFBR2/TNFRSF1B/VCAM1,7
GO:0014028,GO:0014028,notochord formation,2/128,3/18800,0.0001373717174924,0.0011098515908726,0.0005888761407156,EFNA1/EPHA2,2
GO:0060559,GO:0060559,positive regulation of calcidiol 1-monooxygenase activity,2/128,3/18800,0.0001373717174924,0.0011098515908726,0.0005888761407156,IFNG/TNF,2
GO:0001503,GO:0001503,ossification,11/128,420/18800,0.0001421096636844,0.0011429585788677,0.0006064423770319,BAMBI/BCL2/CCL3/CSF1/EPHA2/FGFR2/FSTL3/IL6/STC1/TNF/YAP1,11
GO:1904019,GO:1904019,epithelial cell apoptotic process,6/128,118/18800,0.0001565445575036,0.0012562261007763,0.0006665409899622,ICAM1/IL10/IL6/TGFBR2/TNF/YAP1,6
GO:0006809,GO:0006809,nitric oxide biosynthetic process,5/128,75/18800,0.0001594423076601,0.0012766109431712,0.0006773569832151,IFNG/IL10/KLRK1/NOS3/TNF,5
GO:0010632,GO:0010632,regulation of epithelial cell migration,9/128,290/18800,0.0001677722126203,0.0013373093108641,0.0007095629293152,ADAM9/CXCL13/EFNA1/EPHA2/IFNG/NOS3/STC1/TGFBR2/TNF,9
GO:0050767,GO:0050767,regulation of neurogenesis,10/128,361/18800,0.0001835123282486,0.0014466280886886,0.0007675663781749,B2M/DLL1/IFNG/IL6/NEFL/SEMA3F/THY1/TNF/TNFRSF1B/YAP1,10
GO:0002347,GO:0002347,response to tumor cell,4/128,42/18800,0.0001878063734209,0.0014709272336594,0.000780459261179,CD274/HAVCR2/IL12B/NECTIN2,4
GO:0019730,GO:0019730,antimicrobial humoral response,6/128,122/18800,0.0001878305288571,0.0014709272336594,0.000780459261179,CXCL10/CXCL13/CXCL9/HLA-E/REG3A/WFDC2,6
GO:0032604,GO:0032604,granulocyte macrophage colony-stimulating factor production,3/128,17/18800,0.000195499908957,0.0015143821581036,0.0008035160089571,CD80/IL12B/IL18,3
GO:0031589,GO:0031589,cell-substrate adhesion,10/128,364/18800,0.0001961661701943,0.0015162540990559,0.0008045092420818,ADAM9/AXL/BCL2/CSF1/EFNA1/GBP1/SDC4/SIGLEC1/THY1/VCAM1,10
GO:0014002,GO:0014002,astrocyte development,4/128,43/18800,0.0002059832888522,0.001585272251059,0.0008411295824275,DLL1/IFNG/IL6/TNF,4
GO:0097305,GO:0097305,response to alcohol,8/128,235/18800,0.0002087310981952,0.0016029650573227,0.0008505172082656,CCL3/CD14/CSF3/FGFR2/NEFL/TGFBR2/TNF/VCAM1,8
GO:0060485,GO:0060485,mesenchyme development,9/128,301/18800,0.0002213552330678,0.0016926328421529,0.0008980940370161,BAMBI/BCL2/EFNA1/FGFR2/IL6/NOS3/SEMA3F/TGFBR2/YAP1,9
GO:0046209,GO:0046209,nitric oxide metabolic process,5/128,81/18800,0.0002291171349616,0.0017445144753691,0.0009256219120884,IFNG/IL10/KLRK1/NOS3/TNF,5
GO:2001057,GO:2001057,reactive nitrogen species metabolic process,5/128,82/18800,0.0002426762623797,0.0018290524266078,0.0009704769025023,IFNG/IL10/KLRK1/NOS3/TNF,5
GO:0042542,GO:0042542,response to hydrogen peroxide,6/128,128/18800,0.0002438053640619,0.0018290524266078,0.0009704769025023,ADAM9/AXL/BCL2/IL10/IL18BP/IL6,6
GO:0048565,GO:0048565,digestive tract development,6/128,130/18800,0.0002651247978018,0.0019683173658015,0.0010443694847212,BCL2/CLMP/FGFR2/TGFBR2/TNF/YAP1,6
GO:0071496,GO:0071496,cellular response to external stimulus,9/128,309/18800,0.0002686854915108,0.0019906138800522,0.0010561997919185,AXL/BCL2/DSC2/FOLR2/IL15/LTBR/TNFRSF1A/TNFRSF8/VCAM1,9
GO:0046136,GO:0046136,positive regulation of vitamin metabolic process,2/128,4/18800,0.0002735163672911,0.0020138699950447,0.0010685392536604,IFNG/TNF,2
GO:0034103,GO:0034103,regulation of tissue remodeling,5/128,86/18800,0.0003031061810158,0.0021999840902593,0.0011672895289442,CST3/IL12B/IL15/IL18/IL6,5
GO:1902004,GO:1902004,positive regulation of amyloid-beta formation,3/128,20/18800,0.0003228917771994,0.0022969054509549,0.0012187150324158,EFNA1/IFNG/TNF,3
GO:0051924,GO:0051924,regulation of calcium ion transport,8/128,251/18800,0.0003255074359361,0.0023109086555231,0.0012261449925397,BCL2/CCL3/CXCL10/CXCL9/EPO/NOS3/STC1/THY1,8
GO:0050708,GO:0050708,regulation of protein secretion,8/128,252/18800,0.0003342873996429,0.002368532349454,0.0012567195475297,ADAM9/CCN3/CD200/EZR/IFNG/IL12B/IL6/TNF,8
GO:0035094,GO:0035094,response to nicotine,4/128,49/18800,0.0003426726278286,0.0024183477351309,0.0012831510923479,B2M/BCL2/TNF/VCAM1,4
GO:0002269,GO:0002269,leukocyte activation involved in inflammatory response,4/128,50/18800,0.0003705206801274,0.0025791995102048,0.001368497433527,CCL3/IFNG/IL6/TNF,4
GO:0030857,GO:0030857,negative regulation of epithelial cell differentiation,4/128,50/18800,0.0003705206801274,0.0025791995102048,0.001368497433527,DLL1/IFNG/REG3A/YAP1,4
GO:0045927,GO:0045927,positive regulation of growth,8/128,256/18800,0.0003713635022416,0.0025800370943676,0.0013689418472967,AGRN/BCL2/CSF1/DLL1/EZR/FGFR2/TGFBR2/YAP1,8
GO:0022404,GO:0022404,molting cycle process,5/128,92/18800,0.0004143276591626,0.002850797824412,0.0015126047794195,BCL2/EDAR/FGFR2/TNF/TNFRSF19,5
GO:0022405,GO:0022405,hair cycle process,5/128,92/18800,0.0004143276591626,0.002850797824412,0.0015126047794195,BCL2/EDAR/FGFR2/TNF/TNFRSF19,5
GO:0048013,GO:0048013,ephrin receptor signaling pathway,4/128,52/18800,0.0004310125579727,0.0029429174847432,0.001561482548759,EFNA1/EFNA4/EPHA2/EPHB4,4
GO:1902339,GO:1902339,positive regulation of apoptotic process involved in morphogenesis,2/128,5/18800,0.0004538256963498,0.0030405470200101,0.0016132838025669,TNFRSF1A/TNFRSF1B,2
GO:0051091,GO:0051091,positive regulation of DNA-binding transcription factor activity,8/128,265/18800,0.0004671282124379,0.0031238105741873,0.001657462610661,CD200/CSF3/EDA2R/IL10/IL18/IL6/LGALS9/TNF,8
GO:1990868,GO:1990868,response to chemokine,5/128,97/18800,0.0005284815387375,0.0034755203956386,0.0018440763201077,CCL3/CXCL10/CXCL13/CXCL9/THPO,5
GO:0019233,GO:0019233,sensory perception of pain,5/128,99/18800,0.0005802078971808,0.0037739934441396,0.0020024431309087,CCL3/CCN3/IL10/IL12B/TNF,5
GO:0050679,GO:0050679,positive regulation of epithelial cell proliferation,7/128,211/18800,0.0006098951859069,0.0039598831070433,0.0021010743246556,B4GALT1/FGFR2/IL10/PGF/REG3A/TNF/YAP1,7
GO:2001188,GO:2001188,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,2/128,6/18800,0.000677701385642,0.0042757449613564,0.0022686674616992,HAVCR2/LGALS9,2
GO:0010522,GO:0010522,regulation of calcium ion transport into cytosol,5/128,103/18800,0.0006949606334711,0.0043691979262773,0.0023182526691032,BCL2/CXCL10/CXCL9/EPO/THY1,5
GO:1903076,GO:1903076,regulation of protein localization to plasma membrane,5/128,103/18800,0.0006949606334711,0.0043691979262773,0.0023182526691032,EPHA2/EZR/GBP1/IFNG/TNF,5
GO:0000768,GO:0000768,syncytium formation by plasma membrane fusion,4/128,59/18800,0.0006984861150668,0.0043759542401818,0.0023218375016071,ADAM9/CXCL10/CXCL9/JAM2,4
GO:0140253,GO:0140253,cell-cell fusion,4/128,59/18800,0.0006984861150668,0.0043759542401818,0.0023218375016071,ADAM9/CXCL10/CXCL9/JAM2,4
GO:0045428,GO:0045428,regulation of nitric oxide biosynthetic process,4/128,61/18800,0.0007925505953795,0.004879652027759,0.0025890945039621,IFNG/IL10/KLRK1/TNF,4
GO:0003416,GO:0003416,endochondral bone growth,3/128,28/18800,0.0008917230815078,0.0054000797920437,0.0028652282644338,FGFR2/STC1/TGFBR2,3
GO:0048873,GO:0048873,homeostasis of number of cells within a tissue,3/128,28/18800,0.0008917230815078,0.0054000797920437,0.0028652282644338,BCL2/CSF1/NOS3,3
GO:0060558,GO:0060558,regulation of calcidiol 1-monooxygenase activity,2/128,7/18800,0.0009445511058318,0.0055751933866539,0.0029581417842494,IFNG/TNF,2
GO:0071316,GO:0071316,cellular response to nicotine,2/128,7/18800,0.0009445511058318,0.0055751933866539,0.0029581417842494,B2M/TNF,2
GO:0080164,GO:0080164,regulation of nitric oxide metabolic process,4/128,64/18800,0.0009499217477866,0.0055884193761883,0.0029651593618591,IFNG/IL10/KLRK1/TNF,4
GO:1903034,GO:1903034,regulation of response to wounding,6/128,166/18800,0.0009668385751049,0.0056692619896546,0.0030080536430539,IL10/NOS3/REG3A/SIGLEC10/THBD/TNF,6
GO:0060142,GO:0060142,regulation of syncytium formation by plasma membrane fusion,3/128,30/18800,0.0010942138412605,0.0062921700920152,0.0033385624447309,ADAM9/CXCL10/CXCL9,3
GO:0003149,GO:0003149,membranous septum morphogenesis,2/128,8/18800,0.0012537884644892,0.0069848340197988,0.0037060829888835,FGFR2/TGFBR2,2
GO:0070672,GO:0070672,response to interleukin-15,2/128,8/18800,0.0012537884644892,0.0069848340197988,0.0037060829888835,IL15/IL15RA,2
GO:0033028,GO:0033028,myeloid cell apoptotic process,3/128,32/18800,0.0013235810539239,0.0073235981261241,0.0038858278315151,BCL2/EPO/IL6,3
GO:0001649,GO:0001649,osteoblast differentiation,7/128,241/18800,0.0013248514112226,0.0073235981261241,0.0038858278315151,BAMBI/CCL3/EPHA2/FGFR2/IL6/TNF/YAP1,7
GO:0050766,GO:0050766,positive regulation of phagocytosis,4/128,71/18800,0.0014004328765541,0.0076937627725764,0.0040822334863115,IFNG/IL15/IL15RA/TNF,4
GO:0014902,GO:0014902,myotube differentiation,5/128,122/18800,0.0014852193901237,0.0080972800643233,0.0042963357207275,BCL2/CCN3/CXCL10/CXCL9/JAM2,5
GO:0042176,GO:0042176,regulation of protein catabolic process,9/128,395/18800,0.0015427088830927,0.0083723608229849,0.0044422908167763,ADAM9/CST3/EFNA1/EZR/IFNG/IL10/LAMP3/TNF/TNFRSF1B,9
GO:0034756,GO:0034756,regulation of iron ion transport,2/128,9/18800,0.0016048329537368,0.008566305646927,0.0045451959983105,B2M/IFNG,2
GO:0035924,GO:0035924,cellular response to vascular endothelial growth factor stimulus,4/128,74/18800,0.0016326261520799,0.0087016537150412,0.0046170103279559,DLL1/IL12B/PGF/VCAM1,4
GO:0033280,GO:0033280,response to vitamin D,3/128,35/18800,0.0017207688060316,0.0091441449499092,0.0048517917463298,CXCL10/IL15/STC1,3
GO:0002040,GO:0002040,sprouting angiogenesis,6/128,186/18800,0.0017310689967285,0.0091852115710513,0.0048735812842908,DLL1/EPHA2/EPHB4/IL10/IL12B/PGF,6
GO:0060401,GO:0060401,cytosolic calcium ion transport,6/128,190/18800,0.0019273742501876,0.0101664009563074,0.0053941905470539,BCL2/CCL3/CXCL10/CXCL9/EPO/THY1,6
GO:0062197,GO:0062197,cellular response to chemical stress,8/128,332/18800,0.0019866299673969,0.0103960341791887,0.0055160316357027,AXL/BCL2/EPO/IL10/IL18BP/IL6/NOS3/TNF,8
GO:0019062,GO:0019062,virion attachment to host cell,2/128,10/18800,0.0019971098983263,0.0103960341791887,0.0055160316357027,ICAM1/NECTIN2,2
GO:0045348,GO:0045348,positive regulation of MHC class II biosynthetic process,2/128,10/18800,0.0019971098983263,0.0103960341791887,0.0055160316357027,IFNG/IL10,2
GO:0045191,GO:0045191,regulation of isotype switching,3/128,38/18800,0.0021852414778027,0.0112442324455816,0.0059660771424919,CD28/IL10/TNFSF13,3
GO:0045165,GO:0045165,cell fate commitment,7/128,266/18800,0.002319322335944,0.0118998564104257,0.0063139446532052,BCL2/DLL1/FGFR2/IL12B/IL12RB1/IL6/SLAMF8,7
GO:1900222,GO:1900222,negative regulation of amyloid-beta clearance,2/128,11/18800,0.0024300504041402,0.0122566525327471,0.0065032571029623,IFNG/TNF,2
GO:0009612,GO:0009612,response to mechanical stimulus,6/128,201/18800,0.0025545026950548,0.0128119791067992,0.0067979078224405,CXCL10/LTBR/TGFBR2/TNF/TNFRSF1A/TNFRSF8,6
GO:0072073,GO:0072073,kidney epithelium development,5/128,140/18800,0.0027116738638663,0.0135431991158975,0.0071858858372608,BCL2/DLL1/FGFR2/SDC4/YAP1,5
GO:0007409,GO:0007409,axonogenesis,9/128,430/18800,0.0027374706501827,0.0136149132197807,0.0072239366226784,BCL2/EFNA1/EFNA4/EPHA2/EPHB4/FGFR2/NEFL/SEMA3F/THY1,9
GO:0070555,GO:0070555,response to interleukin-1,5/128,141/18800,0.0027962956199141,0.0138474161475739,0.0073473003480178,CCL3/EPO/GBP1/IL6/LGALS9,5
GO:0035592,GO:0035592,establishment of protein localization to extracellular region,8/128,351/18800,0.0027997296159474,0.0138474161475739,0.0073473003480178,ADAM9/CCN3/CD200/EZR/IFNG/IL12B/IL6/TNF,8
GO:0010212,GO:0010212,response to ionizing radiation,5/128,142/18800,0.0028828139712407,0.0141650007281738,0.0075158075463788,BCL2/CXCL10/THBD/VCAM1/YAP1,5
GO:0010455,GO:0010455,positive regulation of cell fate commitment,2/128,12/18800,0.0029030913071157,0.0141650007281738,0.0075158075463788,IL12B/IL12RB1,2
GO:0051602,GO:0051602,response to electrical stimulus,3/128,42/18800,0.0029155070106994,0.0141650007281738,0.0075158075463788,CD14/EPO/PALM,3
GO:0043523,GO:0043523,regulation of neuron apoptotic process,6/128,207/18800,0.0029553968848636,0.014339296570446,0.0076082871749923,AXL/BCL2/CCL3/IL10/NEFL/TNF,6
GO:0098742,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,7/128,279/18800,0.0030244024264986,0.0146541941180823,0.0077753686605692,DSC2/ICAM1/IL10/NECTIN2/REG3A/TGFBR2/VCAM1,7
GO:0071692,GO:0071692,protein localization to extracellular region,8/128,359/18800,0.0032113728399993,0.0154344716172782,0.0081893760884024,ADAM9/CCN3/CD200/EZR/IFNG/IL12B/IL6/TNF,8
GO:0072659,GO:0072659,protein localization to plasma membrane,7/128,283/18800,0.0032713605967623,0.0157016514664493,0.0083311390409906,EPHA2/EZR/GBP1/IFNG/PALM/TNF/TNFRSF1A,7
GO:0070301,GO:0070301,cellular response to hydrogen peroxide,4/128,90/18800,0.0033353683517755,0.015923616105928,0.0084489112560746,AXL/IL10/IL18BP/IL6,4
GO:0010713,GO:0010713,negative regulation of collagen metabolic process,2/128,13/18800,0.0034156751225875,0.0160280891757689,0.0085043436208003,CST3/IL6,2
GO:0032536,GO:0032536,regulation of cell projection size,2/128,13/18800,0.0034156751225875,0.0160280891757689,0.0085043436208003,EZR/NEFL,2
GO:0042362,GO:0042362,fat-soluble vitamin biosynthetic process,2/128,13/18800,0.0034156751225875,0.0160280891757689,0.0085043436208003,IFNG/TNF,2
GO:0045683,GO:0045683,negative regulation of epidermis development,2/128,13/18800,0.0034156751225875,0.0160280891757689,0.0085043436208003,DLL1/REG3A,2
GO:0060670,GO:0060670,branching involved in labyrinthine layer morphogenesis,2/128,13/18800,0.0034156751225875,0.0160280891757689,0.0085043436208003,FGFR2/IL10,2
GO:1900121,GO:1900121,negative regulation of receptor binding,2/128,13/18800,0.0034156751225875,0.0160280891757689,0.0085043436208003,B2M/IL10,2
GO:0001666,GO:0001666,response to hypoxia,7/128,286/18800,0.0034664810207082,0.0162431667620883,0.0086184616344408,BCL2/EPO/PGF/STC1/TGFBR2/TNF/VCAM1,7
GO:1904646,GO:1904646,cellular response to amyloid-beta,3/128,45/18800,0.003550738160515,0.0165747529035285,0.0087943979207803,ICAM1/TNF/VCAM1,3
GO:1904035,GO:1904035,regulation of epithelial cell apoptotic process,4/128,94/18800,0.0038986117639604,0.018033604415936,0.0095684499251823,ICAM1/IL6/TNF/YAP1,4
GO:0051346,GO:0051346,negative regulation of hydrolase activity,8/128,371/18800,0.0039155606041547,0.0180885729850407,0.0095976156975263,COL6A3/CST3/GZMA/KLRK1/LAMP3/NOS3/TNF/WFDC2,8
GO:0002467,GO:0002467,germinal center formation,2/128,14/18800,0.003967249995047,0.0181628842721962,0.0096370445223815,CXCL13/TNFSF13B,2
GO:0033033,GO:0033033,negative regulation of myeloid cell apoptotic process,2/128,14/18800,0.003967249995047,0.0181628842721962,0.0096370445223815,BCL2/EPO,2
GO:0070278,GO:0070278,extracellular matrix constituent secretion,2/128,14/18800,0.003967249995047,0.0181628842721962,0.0096370445223815,TNFRSF1A/TNFRSF1B,2
GO:0090715,GO:0090715,immunological memory formation process,2/128,14/18800,0.003967249995047,0.0181628842721962,0.0096370445223815,IL12B/IL12RB1,2
GO:0021700,GO:0021700,developmental maturation,7/128,296/18800,0.0041815873887783,0.0190708155368168,0.0101187837598993,AGRN/AXL/BCL2/EPO/IL15/NEFL/PALM,7
GO:0010543,GO:0010543,regulation of platelet activation,3/128,48/18800,0.0042643421981278,0.0193493849930299,0.0102665899239352,IL6/NOS3/THBD,3
GO:0002532,GO:0002532,production of molecular mediator involved in inflammatory response,4/128,97/18800,0.0043610371561802,0.0197129920059744,0.0104595161640566,IL6/LILRB4/SLAMF8/TNF,4
GO:0045807,GO:0045807,positive regulation of endocytosis,4/128,97/18800,0.0043610371561802,0.0197129920059744,0.0104595161640566,AXL/B2M/CD14/DLL1,4
GO:0060043,GO:0060043,regulation of cardiac muscle cell proliferation,3/128,49/18800,0.0045201032570604,0.0203290790062503,0.01078640575727,FGFR2/TGFBR2/YAP1,3
GO:1903543,GO:1903543,positive regulation of exosomal secretion,2/128,15/18800,0.004557269648313,0.0203679723581051,0.010807042180309,IFNG/SDC4,2
GO:0006692,GO:0006692,prostanoid metabolic process,3/128,50/18800,0.0047849702300561,0.0212262468217769,0.0112624340164773,CD74/PTGDS/TNFRSF1A,3
GO:0006693,GO:0006693,prostaglandin metabolic process,3/128,50/18800,0.0047849702300561,0.0212262468217769,0.0112624340164773,CD74/PTGDS/TNFRSF1A,3
GO:0038084,GO:0038084,vascular endothelial growth factor signaling pathway,3/128,50/18800,0.0047849702300561,0.0212262468217769,0.0112624340164773,DLL1/IL12B/PGF,3
GO:0010224,GO:0010224,response to UV-B,2/128,16/18800,0.0051851933361124,0.0227194176727086,0.0120546955182466,BCL2/IL12B,2
GO:0034393,GO:0034393,positive regulation of smooth muscle cell apoptotic process,2/128,16/18800,0.0051851933361124,0.0227194176727086,0.0120546955182466,IFNG/IL12B,2
GO:0045342,GO:0045342,MHC class II biosynthetic process,2/128,16/18800,0.0051851933361124,0.0227194176727086,0.0120546955182466,IFNG/IL10,2
GO:0045190,GO:0045190,isotype switching,3/128,52/18800,0.0053423822228439,0.0232938301804343,0.0123594730430166,CD28/IL10/TNFSF13,3
GO:0034250,GO:0034250,positive regulation of cellular amide metabolic process,5/128,167/18800,0.0057329993056472,0.0248152006308681,0.0131666969699075,CD28/EFNA1/IFNG/IL6/TNF,5
GO:1901890,GO:1901890,positive regulation of cell junction assembly,4/128,105/18800,0.0057717916196839,0.0249528666754131,0.0132397411946362,AGRN/EPHA2/SDC4/THY1,4
GO:0048532,GO:0048532,anatomical structure arrangement,2/128,17/18800,0.0058504857930664,0.0249606747515417,0.0132438840816446,DLL1/SEMA3F,2
GO:0051402,GO:0051402,neuron apoptotic process,6/128,241/18800,0.0061743293080977,0.026248249951449,0.0139270585896942,AXL/BCL2/CCL3/IL10/NEFL/TNF,6
GO:0060249,GO:0060249,anatomical structure homeostasis,7/128,319/18800,0.0062471729090359,0.0263129778023392,0.0139614025392299,B2M/BCL2/CSF1/IL6/JAM2/NOS3/YAP1,7
GO:0001954,GO:0001954,positive regulation of cell-matrix adhesion,3/128,55/18800,0.0062489655914312,0.0263129778023392,0.0139614025392299,CSF1/SDC4/THY1,3
GO:1904645,GO:1904645,response to amyloid-beta,3/128,55/18800,0.0062489655914312,0.0263129778023392,0.0139614025392299,ICAM1/TNF/VCAM1,3
GO:0034138,GO:0034138,toll-like receptor 3 signaling pathway,2/128,18/18800,0.0065526171860803,0.0263129778023392,0.0139614025392299,HAVCR2/TNF,2
GO:0034205,GO:0034205,amyloid-beta formation,3/128,56/18800,0.0065702685052571,0.0263129778023392,0.0139614025392299,EFNA1/IFNG/TNF,3
GO:0031668,GO:0031668,cellular response to extracellular stimulus,6/128,245/18800,0.0066748829668132,0.0263129778023392,0.0139614025392299,AXL/BCL2/DSC2/FOLR2/IL15/VCAM1,6
GO:0044089,GO:0044089,positive regulation of cellular component biogenesis,9/128,494/18800,0.0067212802004688,0.0263129778023392,0.0139614025392299,AGRN/CSF3/CXCL13/EPHA2/IFNG/PALM/SDC4/THY1/TNF,9
GO:0001815,GO:0001815,positive regulation of antibody-dependent cellular cytotoxicity,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,HLA-E,1
GO:0003421,GO:0003421,growth plate cartilage axis specification,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,STC1,1
GO:0010711,GO:0010711,negative regulation of collagen catabolic process,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,CST3,1
GO:0014740,GO:0014740,negative regulation of muscle hyperplasia,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,NOS3,1
GO:0021688,GO:0021688,cerebellar molecular layer formation,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,DLL1,1
GO:0032078,GO:0032078,negative regulation of endodeoxyribonuclease activity,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,GZMA,1
GO:0032113,GO:0032113,regulation of carbohydrate phosphatase activity,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,IFNG,1
GO:0032848,GO:0032848,negative regulation of cellular pH reduction,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,BCL2,1
GO:0035602,GO:0035602,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,FGFR2,1
GO:0035603,GO:0035603,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,FGFR2,1
GO:0035604,GO:0035604,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,FGFR2,1
GO:0035607,GO:0035607,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,FGFR2,1
GO:0044722,GO:0044722,renal phosphate excretion,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,STC1,1
GO:0045887,GO:0045887,positive regulation of synaptic assembly at neuromuscular junction,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,AGRN,1
GO:0045994,GO:0045994,positive regulation of translational initiation by iron,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,TNF,1
GO:0046671,GO:0046671,negative regulation of retinal cell programmed cell death,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,BCL2,1
GO:0060311,GO:0060311,negative regulation of elastin catabolic process,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,CST3,1
GO:0060549,GO:0060549,"regulation of fructose 1,6-bisphosphate 1-phosphatase activity",1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,IFNG,1
GO:0060550,GO:0060550,"positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity",1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,IFNG,1
GO:0060551,GO:0060551,"regulation of fructose 1,6-bisphosphate metabolic process",1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,IFNG,1
GO:0060552,GO:0060552,"positive regulation of fructose 1,6-bisphosphate metabolic process",1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,IFNG,1
GO:0060853,GO:0060853,Notch signaling pathway involved in arterial endothelial cell fate commitment,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,DLL1,1
GO:0060945,GO:0060945,cardiac neuron differentiation,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,VCAM1,1
GO:0071283,GO:0071283,cellular response to iron(III) ion,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,B2M,1
GO:0075512,GO:0075512,clathrin-dependent endocytosis of virus by host cell,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,SIGLEC1,1
GO:0140460,GO:0140460,response to Gram-negative bacterium,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,TNF,1
GO:0150070,GO:0150070,regulation of arginase activity,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,CD200,1
GO:0150072,GO:0150072,positive regulation of arginase activity,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,CD200,1
GO:1901554,GO:1901554,response to paracetamol,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,TNF,1
GO:1902483,GO:1902483,cytotoxic T cell pyroptotic process,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,GZMA,1
GO:1903402,GO:1903402,regulation of renal phosphate excretion,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,STC1,1
GO:1903403,GO:1903403,negative regulation of renal phosphate excretion,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,STC1,1
GO:1905317,GO:1905317,inferior endocardial cushion morphogenesis,1/128,1/18800,0.0068085106382977,0.0263129778023392,0.0139614025392299,TGFBR2,1
GO:0007204,GO:0007204,positive regulation of cytosolic calcium ion concentration,7/128,325/18800,0.0068933708198106,0.0265850720932662,0.0141057730454035,BCL2/CCL3/CXCL10/CXCL13/CXCL9/EPO/THY1,7
GO:0010544,GO:0010544,negative regulation of platelet activation,2/128,19/18800,0.0072910630661318,0.0276688482562773,0.0146808138251998,NOS3/THBD,2
GO:0010744,GO:0010744,positive regulation of macrophage derived foam cell differentiation,2/128,19/18800,0.0072910630661318,0.0276688482562773,0.0146808138251998,CSF1/IL18,2
GO:0048643,GO:0048643,positive regulation of skeletal muscle tissue development,2/128,19/18800,0.0072910630661318,0.0276688482562773,0.0146808138251998,BCL2/DLL1,2
GO:0060759,GO:0060759,regulation of response to cytokine stimulus,5/128,178/18800,0.0074640766606116,0.0282953479352911,0.015013228281485,AXL/CD74/CSF1/IL6/TNFRSF1A,5
GO:0051235,GO:0051235,maintenance of location,7/128,331/18800,0.0075880698489315,0.0286605692739043,0.0152070110666414,CCL3/CXCL10/CXCL9/IL10/IL6/THY1/TNF,7
GO:0031102,GO:0031102,neuron projection regeneration,3/128,59/18800,0.0075925226919948,0.0286605692739043,0.0152070110666414,BCL2/NEFL/THY1,3
GO:0045599,GO:0045599,negative regulation of fat cell differentiation,3/128,59/18800,0.0075925226919948,0.0286605692739043,0.0152070110666414,IL6/TNF/YAP1,3
GO:0002791,GO:0002791,regulation of peptide secretion,5/128,180/18800,0.007813971840945,0.0294342757848256,0.0156175319938941,CCN3/CD74/IFNG/IL6/TNF,5
GO:0090288,GO:0090288,negative regulation of cellular response to growth factor stimulus,4/128,115/18800,0.0079256879973515,0.0297922440405708,0.0158074663659089,BAMBI/CXCL13/FSTL3/IL12B,4
GO:0061614,GO:0061614,miRNA transcription,3/128,60/18800,0.0079529466004985,0.0298319036873741,0.0158285093773743,IL10/LILRB4/TNF,3
GO:0035455,GO:0035455,response to interferon-alpha,2/128,20/18800,0.0080653043204576,0.0299077899567543,0.0158687738720269,AXL/LAMP3,2
GO:0042359,GO:0042359,vitamin D metabolic process,2/128,20/18800,0.0080653043204576,0.0299077899567543,0.0158687738720269,IFNG/TNF,2
GO:1903978,GO:1903978,regulation of microglial cell activation,2/128,20/18800,0.0080653043204576,0.0299077899567543,0.0158687738720269,CCL3/IL6,2
GO:0048469,GO:0048469,cell maturation,5/128,183/18800,0.0083599929584692,0.0308086015012319,0.0163467354573295,AGRN/AXL/BCL2/EPO/IL15,5
GO:0043500,GO:0043500,muscle adaptation,4/128,118/18800,0.0086619789593553,0.0318229700245453,0.0168849492385095,IL15/NOS3/TNFRSF1A/TNFRSF1B,4
GO:0097734,GO:0097734,extracellular exosome biogenesis,2/128,21/18800,0.0088748271251319,0.0323387833304554,0.0171586346135742,IFNG/SDC4,2
GO:0031345,GO:0031345,negative regulation of cell projection organization,5/128,188/18800,0.0093279612556213,0.0339553003504828,0.0180163423575496,B2M/EFNA1/SEMA3F/THY1/YAP1,5
GO:0050918,GO:0050918,positive chemotaxis,3/128,64/18800,0.009494633703241,0.034351911807775,0.0182267804253548,CCL3/CXCL10/PGF,3
GO:0006979,GO:0006979,response to oxidative stress,8/128,433/18800,0.0096320409241419,0.0347417295984858,0.0184336138416998,ADAM9/AXL/BCL2/IL10/IL18BP/IL6/NOS3/TNF,8
GO:0010888,GO:0010888,negative regulation of lipid storage,2/128,22/18800,0.0097191228980362,0.0347417295984858,0.0184336138416998,IL6/TNF,2
GO:1903798,GO:1903798,regulation of production of miRNAs involved in gene silencing by miRNA,2/128,22/18800,0.0097191228980362,0.0347417295984858,0.0184336138416998,IL6/TNF,2
GO:0014823,GO:0014823,response to activity,3/128,65/18800,0.0099053290892229,0.0352661317822684,0.0187118563893596,IL10/IL6/TNF,3
GO:0045861,GO:0045861,negative regulation of proteolysis,7/128,350/18800,0.0101318111369072,0.0360006940993985,0.0191016077993537,COL6A3/CST3/EFNA1/IL10/LAMP3/TNF/WFDC2,7
GO:0046847,GO:0046847,filopodium assembly,3/128,66/18800,0.0103262352733474,0.0365460715174663,0.0193909795962916,AGRN/EZR/PALM,3
GO:0002053,GO:0002053,positive regulation of mesenchymal cell proliferation,2/128,23/18800,0.0105976882522162,0.0370659595971244,0.0196668270055046,FGFR2/TGFBR2,2
GO:0010893,GO:0010893,positive regulation of steroid biosynthetic process,2/128,23/18800,0.0105976882522162,0.0370659595971244,0.0196668270055046,IFNG/TNF,2
GO:0035988,GO:0035988,chondrocyte proliferation,2/128,23/18800,0.0105976882522162,0.0370659595971244,0.0196668270055046,CCN3/STC1,2
GO:1900120,GO:1900120,regulation of receptor binding,2/128,23/18800,0.0105976882522162,0.0370659595971244,0.0196668270055046,B2M/IL10,2
GO:0071300,GO:0071300,cellular response to retinoic acid,3/128,67/18800,0.0107573985742846,0.0375509973692769,0.0199241831905256,FGFR2/TNF/YAP1,3
GO:0120032,GO:0120032,regulation of plasma membrane bounded cell projection assembly,5/128,195/18800,0.0108092589449897,0.037695179387264,0.0200006847255155,AGRN/EPHA2/ICAM1/PALM/YAP1,5
GO:0019835,GO:0019835,cytolysis,2/128,24/18800,0.0115100249496232,0.0396357754051151,0.0210303455405996,GZMA/GZMH,2
GO:1901863,GO:1901863,positive regulation of muscle tissue development,2/128,24/18800,0.0115100249496232,0.0396357754051151,0.0210303455405996,BCL2/DLL1,2
GO:0009988,GO:0009988,cell-cell recognition,3/128,69/18800,0.0116506697057681,0.040042869604714,0.0212463456465048,B4GALT1/FOLR2/HAVCR2,3
GO:0003143,GO:0003143,embryonic heart tube morphogenesis,3/128,70/18800,0.0121128581947531,0.0413527883493913,0.0219413754156743,DLL1/TGFBR2/YAP1,3
GO:0071260,GO:0071260,cellular response to mechanical stimulus,3/128,70/18800,0.0121128581947531,0.0413527883493913,0.0219413754156743,LTBR/TNFRSF1A/TNFRSF8,3
GO:0035821,GO:0035821,modulation of process of another organism,2/128,25/18800,0.0124556398552367,0.0423207325623693,0.0224549569226561,IFNG/REG3A,2
GO:0060074,GO:0060074,synapse maturation,2/128,25/18800,0.0124556398552367,0.0423207325623693,0.0224549569226561,NEFL/PALM,2
GO:1904427,GO:1904427,positive regulation of calcium ion transmembrane transport,3/128,71/18800,0.0125854651940854,0.0425479638927743,0.022575523591208,CXCL10/CXCL9/THY1,3
GO:0042246,GO:0042246,tissue regeneration,3/128,72/18800,0.0130685252735143,0.0425479638927743,0.022575523591208,CCN3/TGFBR2/YAP1,3
GO:0051894,GO:0051894,positive regulation of focal adhesion assembly,2/128,26/18800,0.0134340448915652,0.0425479638927743,0.022575523591208,SDC4/THY1,2
GO:0060561,GO:0060561,apoptotic process involved in morphogenesis,2/128,26/18800,0.0134340448915652,0.0425479638927743,0.022575523591208,TNFRSF1A/TNFRSF1B,2
GO:0002037,GO:0002037,negative regulation of L-glutamate import across plasma membrane,1/128,2/18800,0.0135710251677037,0.0425479638927743,0.022575523591208,TNF,1
GO:0002384,GO:0002384,hepatic immune response,1/128,2/18800,0.0135710251677037,0.0425479638927743,0.022575523591208,IL6,1
GO:0005988,GO:0005988,lactose metabolic process,1/128,2/18800,0.0135710251677037,0.0425479638927743,0.022575523591208,B4GALT1,1
GO:0005989,GO:0005989,lactose biosynthetic process,1/128,2/18800,0.0135710251677037,0.0425479638927743,0.022575523591208,B4GALT1,1
GO:0014806,GO:0014806,smooth muscle hyperplasia,1/128,2/18800,0.0135710251677037,0.0425479638927743,0.022575523591208,NOS3,1
GO:0021693,GO:0021693,cerebellar Purkinje cell layer structural organization,1/128,2/18800,0.0135710251677037,0.0425479638927743,0.022575523591208,DLL1,1
GO:0021847,GO:0021847,ventricular zone neuroblast division,1/128,2/18800,0.0135710251677037,0.0425479638927743,0.022575523591208,FGFR2,1
GO:0030382,GO:0030382,sperm mitochondrion organization,1/128,2/18800,0.0135710251677037,0.0425479638927743,0.022575523591208,NECTIN2,1
GO:0042488,GO:0042488,positive regulation of odontogenesis of dentin-containing tooth,1/128,2/18800,0.0135710251677037,0.0425479638927743,0.022575523591208,CSF1,1
GO:0045105,GO:0045105,intermediate filament polymerization or depolymerization,1/128,2/18800,0.0135710251677037,0.0425479638927743,0.022575523591208,NEFL,1
GO:0060302,GO:0060302,negative regulation of cytokine activity,1/128,2/18800,0.0135710251677037,0.0425479638927743,0.022575523591208,IL10,1
GO:0060313,GO:0060313,negative regulation of blood vessel remodeling,1/128,2/18800,0.0135710251677037,0.0425479638927743,0.022575523591208,CST3,1
GO:0060529,GO:0060529,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,1/128,2/18800,0.0135710251677037,0.0425479638927743,0.022575523591208,FGFR2,1
GO:0060595,GO:0060595,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,1/128,2/18800,0.0135710251677037,0.0425479638927743,0.022575523591208,FGFR2,1
GO:0071231,GO:0071231,cellular response to folic acid,1/128,2/18800,0.0135710251677037,0.0425479638927743,0.022575523591208,FOLR2,1
GO:0072564,GO:0072564,blood microparticle formation,1/128,2/18800,0.0135710251677037,0.0425479638927743,0.022575523591208,TNF,1
GO:0097102,GO:0097102,endothelial tip cell fate specification,1/128,2/18800,0.0135710251677037,0.0425479638927743,0.022575523591208,DLL1,1
GO:0120190,GO:0120190,negative regulation of bile acid secretion,1/128,2/18800,0.0135710251677037,0.0425479638927743,0.022575523591208,TNF,1
GO:0150073,GO:0150073,regulation of protein-glutamine gamma-glutamyltransferase activity,1/128,2/18800,0.0135710251677037,0.0425479638927743,0.022575523591208,CD200,1
GO:0150074,GO:0150074,positive regulation of protein-glutamine gamma-glutamyltransferase activity,1/128,2/18800,0.0135710251677037,0.0425479638927743,0.022575523591208,CD200,1
GO:1904398,GO:1904398,positive regulation of neuromuscular junction development,1/128,2/18800,0.0135710251677037,0.0425479638927743,0.022575523591208,AGRN,1
GO:1904432,GO:1904432,regulation of ferrous iron binding,1/128,2/18800,0.0135710251677037,0.0425479638927743,0.022575523591208,B2M,1
GO:1904434,GO:1904434,positive regulation of ferrous iron binding,1/128,2/18800,0.0135710251677037,0.0425479638927743,0.022575523591208,B2M,1
GO:1904437,GO:1904437,positive regulation of transferrin receptor binding,1/128,2/18800,0.0135710251677037,0.0425479638927743,0.022575523591208,B2M,1
GO:1990267,GO:1990267,response to transition metal nanoparticle,1/128,2/18800,0.0135710251677037,0.0425479638927743,0.022575523591208,TNF,1
GO:1990268,GO:1990268,response to gold nanoparticle,1/128,2/18800,0.0135710251677037,0.0425479638927743,0.022575523591208,TNF,1
GO:0042886,GO:0042886,amide transport,6/128,287/18800,0.0138458408008917,0.0433334772129573,0.0229923090932286,CCN3/CD74/FOLR2/IFNG/IL6/TNF,6
GO:0010977,GO:0010977,negative regulation of neuron projection development,4/128,136/18800,0.0140232692242491,0.0438503453588385,0.0232665541558194,B2M/EFNA1/SEMA3F/THY1,4
GO:0009880,GO:0009880,embryonic pattern specification,3/128,74/18800,0.0140661318064376,0.0438691324723046,0.0232765224101013,DLL1/FGFR2/SEMA3F,3
GO:0003401,GO:0003401,axis elongation,2/128,27/18800,0.0144447569935229,0.0445827374450044,0.0236551540629952,FGFR2/YAP1,2
GO:0009651,GO:0009651,response to salt stress,2/128,27/18800,0.0144447569935229,0.0445827374450044,0.0236551540629952,EPO/TNF,2
GO:0032607,GO:0032607,interferon-alpha production,2/128,27/18800,0.0144447569935229,0.0445827374450044,0.0236551540629952,HAVCR2/IL10,2
GO:0055074,GO:0055074,calcium ion homeostasis,8/128,468/18800,0.0148282249310934,0.0456086057096765,0.0241994694917884,BCL2/CCL3/CXCL10/CXCL13/CXCL9/EPO/STC1/THY1,8
GO:0043299,GO:0043299,leukocyte degranulation,3/128,76/18800,0.0151059102819488,0.0463828079250551,0.0246102534348624,CCL3/LGALS9/PTGDS,3
GO:0030431,GO:0030431,sleep,2/128,28/18800,0.0154872980636778,0.0473097873271117,0.0251020994233669,IL18/PTGDS,2
GO:0033688,GO:0033688,regulation of osteoblast proliferation,2/128,28/18800,0.0154872980636778,0.0473097873271117,0.0251020994233669,BCL2/FGFR2,2
GO:0070723,GO:0070723,response to cholesterol,2/128,28/18800,0.0154872980636778,0.0473097873271117,0.0251020994233669,CCL3/TGFBR2,2
GO:0050803,GO:0050803,regulation of synapse structure or activity,5/128,215/18800,0.0159104687349633,0.0485609263697041,0.0257659412711955,AGRN/EFNA1/IL10/SEMA3F/TNF,5
